GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (HKSE:02268) » Definitions » EPS (Basic)

WuXi XDC Cayman (HKSE:02268) EPS (Basic) : HK$0.95 (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman EPS (Basic)?

WuXi XDC Cayman's basic earnings per share (Basic EPS) for the six months ended in Jun. 2024 was HK$0.44. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.95.

WuXi XDC Cayman's EPS (Diluted) for the six months ended in Jun. 2024 was HK$0.41. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.89.

WuXi XDC Cayman's EPS without NRI for the six months ended in Jun. 2024 was HK$0.44. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was 0.98.

During the past 12 months, WuXi XDC Cayman's average EPS without NRIGrowth Rate was 120.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 152.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, WuXi XDC Cayman's highest 3-Year average EPS without NRI Growth Rate was 152.00% per year. The lowest was 152.00% per year. And the median was 152.00% per year.


WuXi XDC Cayman EPS (Basic) Historical Data

The historical data trend for WuXi XDC Cayman's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman EPS (Basic) Chart

WuXi XDC Cayman Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
EPS (Basic)
0.03 0.06 0.15 0.31 0.95

WuXi XDC Cayman Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EPS (Basic) Get a 7-Day Free Trial 0.05 0.16 0.14 0.44 0.51

WuXi XDC Cayman EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

WuXi XDC Cayman's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(310.128-0)/1022.997
=0.30

WuXi XDC Cayman's Basic EPS for the quarter that ended in Jun. 2024 is calculated as

Basic EPS (Q: Jun. 2024 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(525.599-0)/1197.719
=0.44

EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WuXi XDC Cayman  (HKSE:02268) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


WuXi XDC Cayman EPS (Basic) Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


WuXi XDC Cayman Business Description

Traded in Other Exchanges
Address
No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN
WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.
Executives
Shang Hai He Quan Yao Ye Gu Fen You Xian Gong Si
He Quan Yao Ye Xiang Gang Tou Zi You Xian Gong Si
Shang Hai Yao Ming Kang De Xin Yao Kai Fa You Xian Gong Si
Wu Xi Yao Ming Kang De Xin Yao Kai Fa Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you
Wuxi Biologics (cayman) Inc. 2101 Beneficial owner
Wuxi Apptec Co., Ltd.

WuXi XDC Cayman Headlines

No Headlines